JAMA Network | JAMA | Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sust
Research from JAMA — Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation — A Randomized Controlled Trial — ContextThe α4β2 nicotinic acetylcholine receptors (nAChRs ......